Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 105

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 6
Chunk 105
---
 provides for executive employees to receive a combination of short-term incentive as
part of their total remuneration if they achieve certain performance indicators as set by the Board. The short-term incentive can be paid
either by cash, or a combination of cash and the issue of equity in the Company, at the determination of the remuneration and nomination
committee and Board.

Our Chief Executive Officer
is entitled to short-term incentives in the form of cash bonus up to 50% of his base salary, against agreed KPIs. On an annual basis,
KPIs are reviewed and agreed in advance of each financial year and include financial and non-financial and individual performance goals.
Additional shares or options can be granted at the discretion of the board based on performance.

Executives may also be provided
with longer-term incentives through our Omnibus Incentive Plan that was approved by shareholders at the annual general meeting in October
2021. The aim of the Omnibus Incentive Plan is to allow executives to participate in, and benefit from, the growth of the Company as a
result of their efforts and to assist in motivating and retaining those key employees over the long-term. Continued service is the condition
attached to the vesting of the options. The Board, as recommended by the Remuneration and Nomination Committee, determines the total number
of options granted to each executive.

We aim to align our executive
remuneration to our strategic and business objectives and the creation of shareholder wealth. However, these are not necessarily consistent
with the measures used in determining the variable amounts of remuneration to be awarded to key management personnel. As a consequence,
there may not always be a direct correlation between the statutory key performance measures and the variable remuneration awarded.

Director Compensation

Each non-executive Director
receives a fee of A$50,000 per annum. A non-executive Director who is chair of a committee receives an additional A$10,000 per annum and
a non-executive Director who is a member of a committee an extra A$5,000 per annum. They do not receive performance-based pay or retirement
allowances. Fees are reviewed annually by the board taking into account comparable roles and market data provided by the board’s
independent remuneration adviser.

The maximum annual aggregate
non-executive directors’ fee pool limit is A$500,000 and was approved by shareholders in October 2021.

Executive Director and Executive Officer Remuneration

Our remuneration and nomination